Aubrey Rankin

Insider Reports History

Location
C/O Revance Therapeutics, Inc, 7555 Gateway Blvd, Newark, CA
Signature
/s/ Dwight Moxie, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Aubrey Rankin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Revance Therapeutics, Inc. Director Common Stock 322K $2.4M $7.47 Mar 15, 2022 Aubrey and Luanne Rankin Revocable Living Trust Dated July 1, 2009
Revance Therapeutics, Inc. Director Common Stock 154K $1.15M $7.47 Mar 15, 2022 The Rankin Irrevocable Trust
Revance Therapeutics, Inc. Director Common Stock 94.1K $703K $7.47 Mar 15, 2022 Direct

Insider Reports Filed by Aubrey Rankin

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RVNC Revance Therapeutics, Inc. Mar 15, 2022 1 -$21.7K 4 Mar 17, 2022 Director
RVNC Revance Therapeutics, Inc. Dec 3, 2021 1 $433K 4 Dec 6, 2021 President, Innovation & Tech, Director
RVNC Revance Therapeutics, Inc. Aug 15, 2021 2 -$375K 4 Aug 17, 2021 President, Innovation & Tech, Director
RVNC Revance Therapeutics, Inc. Jul 28, 2021 2 -$1.63M 4 Jul 30, 2021 President, Innovation & Tech, Director
RVNC Revance Therapeutics, Inc. Jul 26, 2021 1 -$1.65M 4 Jul 28, 2021 President, Innovation & Tech, Director